164 related articles for article (PubMed ID: 29154799)
21. Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis.
Bai X; Hong W; Cai P; Chen Y; Xu C; Cao D; Yu W; Zhao Z; Huang M; Jin J
Toxicol Appl Pharmacol; 2017 Jun; 324():12-25. PubMed ID: 28366540
[TBL] [Abstract][Full Text] [Related]
22. Valproic acid II: effects on oxidative stress, mitochondrial membrane potential, and cytotoxicity in glutathione-depleted rat hepatocytes.
Tong V; Teng XW; Chang TK; Abbott FS
Toxicol Sci; 2005 Aug; 86(2):436-43. PubMed ID: 15858222
[TBL] [Abstract][Full Text] [Related]
23. Valproic acid triggers increased mitochondrial biogenesis in POLG-deficient fibroblasts.
Sitarz KS; Elliott HR; Karaman BS; Relton C; Chinnery PF; Horvath R
Mol Genet Metab; 2014 May; 112(1):57-63. PubMed ID: 24725338
[TBL] [Abstract][Full Text] [Related]
24. Short-time gene expression response to valproic acid and valproic acid analogs in mouse embryonic stem cells.
Jergil M; Forsberg M; Salter H; Stockling K; Gustafson AL; Dencker L; Stigson M
Toxicol Sci; 2011 Jun; 121(2):328-42. PubMed ID: 21427059
[TBL] [Abstract][Full Text] [Related]
25. PXR-mediated expression of FABP4 promotes valproate-induced lipid accumulation in HepG2 cells.
Yan L; Yang K; Wang S; Xie Y; Zhang L; Tian X
Toxicol Lett; 2021 Aug; 346():47-56. PubMed ID: 33901630
[TBL] [Abstract][Full Text] [Related]
26. Toxicity of valproic acid in mice with decreased plasma and tissue carnitine stores.
Knapp AC; Todesco L; Beier K; Terracciano L; Sägesser H; Reichen J; Krähenbühl S
J Pharmacol Exp Ther; 2008 Feb; 324(2):568-75. PubMed ID: 17986647
[TBL] [Abstract][Full Text] [Related]
27. Application of high-throughput transcriptomics for mechanism-based biological read-across of short-chain carboxylic acid analogues of valproic acid.
Vrijenhoek NG; Wehr MM; Kunnen SJ; Wijaya LS; Callegaro G; Moné MJ; Escher SE; Van de Water B
ALTEX; 2022; 39(2):207–220. PubMed ID: 35040482
[TBL] [Abstract][Full Text] [Related]
28. Aberrant miR199a-5p/caveolin1/PPARα axis in hepatic steatosis.
Li B; Zhang Z; Zhang H; Quan K; Lu Y; Cai D; Ning G
J Mol Endocrinol; 2014 Dec; 53(3):393-403. PubMed ID: 25312970
[TBL] [Abstract][Full Text] [Related]
29. Chenodeoxycholic acid significantly impacts the expression of miRNAs and genes involved in lipid, bile acid and drug metabolism in human hepatocytes.
Krattinger R; Boström A; Lee SML; Thasler WE; Schiöth HB; Kullak-Ublick GA; Mwinyi J
Life Sci; 2016 Jul; 156():47-56. PubMed ID: 27174168
[TBL] [Abstract][Full Text] [Related]
30. Dysregulations of UDP-glucuronosyltransferases in rats with valproic acid and high fat diet induced fatty liver.
Zhang L; Chu X; Wang H; Xie H; Guo C; Cao L; Zhou X; Wang G; Hao H
Eur J Pharmacol; 2013 Dec; 721(1-3):277-85. PubMed ID: 24056123
[TBL] [Abstract][Full Text] [Related]
31. Genomics of human fatty liver disease reveal mechanistically linked lipid droplet-associated gene regulations in bland steatosis and nonalcoholic steatohepatitis.
Sahini N; Borlak J
Transl Res; 2016 Nov; 177():41-69. PubMed ID: 27376874
[TBL] [Abstract][Full Text] [Related]
32. A new approach on valproic acid induced hepatotoxicity: involvement of lysosomal membrane leakiness and cellular proteolysis.
Pourahmad J; Eskandari MR; Kaghazi A; Shaki F; Shahraki J; Fard JK
Toxicol In Vitro; 2012 Jun; 26(4):545-51. PubMed ID: 22342442
[TBL] [Abstract][Full Text] [Related]
33. Effects of linoleate on cell viability and lipid metabolic homeostasis in goose primary hepatocytes.
Pan Z; Wang J; Tang H; Li L; Lv J; Han C; Xia L; Xu F
Comp Biochem Physiol A Mol Integr Physiol; 2011 Jun; 159(2):113-8. PubMed ID: 21295151
[TBL] [Abstract][Full Text] [Related]
34. Glutathione depletion by valproic acid in sandwich-cultured rat hepatocytes: Role of biotransformation and temporal relationship with onset of toxicity.
Kiang TK; Teng XW; Surendradoss J; Karagiozov S; Abbott FS; Chang TK
Toxicol Appl Pharmacol; 2011 May; 252(3):318-24. PubMed ID: 21397622
[TBL] [Abstract][Full Text] [Related]
35. Valproate activates ERK signaling pathway in primary human hepatocytes.
Bitman M; Vrzal R; Dvorak Z; Pavek P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):39-43. PubMed ID: 23073524
[TBL] [Abstract][Full Text] [Related]
36. Valproic acid augments vitamin D receptor-mediated induction of CYP24 by vitamin D3: a possible cause of valproic acid-induced osteomalacia?
Vrzal R; Doricakova A; Novotna A; Bachleda P; Bitman M; Pavek P; Dvorak Z
Toxicol Lett; 2011 Feb; 200(3):146-53. PubMed ID: 21115105
[TBL] [Abstract][Full Text] [Related]
37. Valproic acid derivatives signal for apoptosis and repair in vitro.
Neuman MG; Nanau RM; Shekh-Ahmad T; Yagen B; Bialer M
Clin Biochem; 2013 Oct; 46(15):1532-7. PubMed ID: 23868021
[TBL] [Abstract][Full Text] [Related]
38. Effect of glycine on valproate toxicity in rat hepatocytes.
Vance MA; Gray PD; Tolman KG
Epilepsia; 1994; 35(5):1016-22. PubMed ID: 7925144
[TBL] [Abstract][Full Text] [Related]
39. The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies.
Kesterson JW; Granneman GR; Machinist JM
Hepatology; 1984; 4(6):1143-52. PubMed ID: 6437960
[TBL] [Abstract][Full Text] [Related]
40. In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
Neri P; Tagliaferri P; Di Martino MT; Calimeri T; Amodio N; Bulotta A; Ventura M; Eramo PO; Viscomi C; Arbitrio M; Rossi M; Caraglia M; Munshi NC; Anderson KC; Tassone P
Br J Haematol; 2008 Nov; 143(4):520-31. PubMed ID: 18986388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
